Showing results (491-500 of 683) with videos related to

Sort By:
Pageof 69
Journal of Magnetic Resonance Imaging : JMRI|February 23, 2017
Intravoxel incoherent motion MRI assessment of chemoradiation-induced pelvic bone marrow changes in cervical cancer and correlation with hematological toxicityElaine Yuen Phin Lee, Jose Angelo Udal Perucho, Vince Vardhanabhuti, et al.
Technology in Cancer Research & Treatment|August 3, 2018
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and ControversiesStephanie K Schaub, Pehr E Hartvigson, Michael I Lock, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?Mustafa Adli, Nina A Mayr, Heather S Kaiser, et al.
Expert Review of Anticancer Therapy|December 3, 2008
Stereotactic body radiation therapy for nonpulmonary primary tumorsSimon S Lo, Higinia R Cardenes, Bin S Teh, et al.
Neuromuscular Disorders : NMD|October 21, 2006
Deficiency of mitochondrial ATP synthase of nuclear genetic originW Sperl, P Jesina, J Zeman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
International outreach: what is the responsibility of ASTRO and the major international radiation oncology societies?Nina A Mayr, Kenneth S Hu, Zhongxing Liao, et al.
Cancer|May 27, 2020
Outcomes among pediatric patients with cancer who are treated on trial versus off trial: A matched cohort studyMarilyn M Schapira, Evelyn M Stevens, James E Sharpe, et al.
Annals of Surgery|October 23, 2019
Comparing Outcomes and Costs of Surgical Patients Treated at Major Teaching and Nonteaching Hospitals: A National Matched AnalysisJeffrey H Silber, Paul R Rosenbaum, Bijan A Niknam, et al.
The Milbank Quarterly|December 12, 2018
Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid InsuranceJeffrey H Silber, Paul R Rosenbaum, Richard N Ross, et al.
Nature|June 23, 2012
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersLuis A Diaz, Richard T Williams, Jian Wu, et al.
Pageof 69